Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199312 · ClinicalTrials.gov registry record · NA
Magnetic Muscle Stimulation of Abdominal Muscle
A NA study, sponsored by Zeltiq Aesthetics.
- Terminated
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04199312: Clinical Trial NA study, sponsored by Zeltiq Aesthetics.
NCT04199312 is a NA study that was terminated before completion, run by Zeltiq Aesthetics. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04199312, a NA study, was terminated before completion, sponsored by Zeltiq Aesthetics.
- TERMINATED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Evaluate the safety and efficacy of magnetic muscle stimulation (MMS) of abdominal muscle.
Primary Outcome
Measurement of participant's perception about body shape, assessed using the Body Satisfaction Questionnaire (BSQ) at the 1-month post-treatment follow-up visit. The scale measures body image using a set of dichotomous items used to describe aspects of shape and appearance. The questionnaire has total score range from 10 to 50. An increase in score (when compared to baseline) reflects the participant's perceived improvement in appearance in the treated region (abdomen). Questionnaire results wer
Interventions
- DEVICE Magnetic Muscle Stimulation (MMS) device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-11-13 |
| Est. Completion | 2021-09-29 |
| Phase | NA |
Why NCT04199312 stopped before completion
NCT04199312 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Magnetic Muscle Stimulation (MMS) device is the first listed.
NCT04199312 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04199312 about?
NCT04199312 is a clinical study titled "Magnetic Muscle Stimulation of Abdominal Muscle". Evaluate the safety and efficacy of magnetic muscle stimulation (MMS) of abdominal muscle.
What is the current status of trial NCT04199312?
This trial is currently terminated. It is a NA study. The enrollment target is 30 participants. The study started on 2019-11-13. Estimated completion is 2021-09-29.
What interventions are being tested in trial NCT04199312?
The interventions under investigation include: Magnetic Muscle Stimulation (MMS) device (DEVICE).
Who is sponsoring clinical trial NCT04199312?
This trial is sponsored by Zeltiq Aesthetics, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04199312's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI